BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:1090@bioscience.fi
DTSTART;TZID=Europe/Helsinki;VALUE=DATE:20230116
DTEND;TZID=Europe/Helsinki;VALUE=DATE:20230117
DTSTAMP:20250304T083759Z
URL:https://bioscience.fi/events/lahesmaa-profi7/
SUMMARY:Academy of Finland PROFI7 funding to strengthen immunology research
  at University of Turku
DESCRIPTION:The Academy of Finland has taken decisions on the latest round 
 of PROFI funding\, a funding scheme aimed at bolstering the research profi
 les of Finnish universities. University of Turku was granted 12.3 million 
 euros in the Profi 7 call. The granted funding supports the following thre
 e profiling areas at the University of Turku during the funding term 2023
 –2028: Capitalising Immunity to Combat Disease (IMMUNOCAP)\, Evolution t
 hrough Contact and Communication Networks (Human Diversity) and Sustainabl
 e Materials and Manufacturing (SUSMAT). These chosen profiling areas stren
 gthen the strategic research and education profiles defined in the Univers
 ity’s strategy.\n\nProfessor Riitta Lahesmaa is the director of IMMUNOCA
 P\n\n 	Capitalising Immunity to Combat Disease (IMMUNOCAP) focuses on the 
 immune system from basic mechanisms to innovative solutions in preventing\
 , diagnosing\, and treating immune-mediated diseases. IMMUNOCAP connects t
 o the strategic research and education profile of “Health\, diagnostics 
 and drug development” and it is also linked to the InFLAMES flagship.\n\
 nRead the full article here\n\nLue suomenkielinen uutinen
ATTACH;FMTTYPE=image/jpeg:https://bioscience.fi/wp-content/uploads/2021/01
 /Riitta-Lahesmaa-Director-of-Turku-Bioscience_use-this.jpg
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:STANDARD
DTSTART:20221030T030000
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR